Skip to content

PEG ratio at other companies

Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
1.1×+1.1×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.2×
TG Therapeutics logo
TG TherapeuticsTGTX
Incyte logo
IncyteINCY
Viatris logo
ViatrisVTRS
0.1×

Other financials

Income statement

See full
Revenue$106.5M+159%
Operating income$72.6M+349%
Net income$40.8M+209%
EPS (diluted)$0.24+204%

Balance sheet

See full
Cash & equivalents$220.5M+103%
Total debt$212.4M+1,323%
Total equity-$217.1M+35.0%
Total assets$434.6M+32.8%

Cash flow

See full
Operating cash flow$5.1M-74.3%
CapEx-
Free cash flow$74.6M+390%

Valuation

See full
Market cap$632.12M+457%
Enterprise value$624M+3,024%
P/E6.2×
P/S1.8×+1.4×

Profitability

See full
Gross margin99.2%
Operating margin55.4%+38.7pp
Net margin28.3%+22.3pp
FCF margin24.7%-11.1pp

Returns & leverage

See full
Return on equity29.7%-138pp
Debt / equity-0.5×
Current ratio1.4×-1.9×

Where this comes from

Calculated from Ironwood Pharmaceuticals’s reported figures.

Based on the most recent quarter.

The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ironwood Pharmaceuticals's peg ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ironwood Pharmaceuticals's PEG ratio?
Ironwood Pharmaceuticals (IRWD) reported PEG ratio of 0× in Q4 2025.
What is the long-term trend for Ironwood Pharmaceuticals's PEG ratio?
Over 2 years (2020 to 2025), Ironwood Pharmaceuticals's PEG ratio has grown at a -55.5% compound annual growth rate (CAGR), from 0× to 0×.
What does PEG ratio mean?
The P/E ratio divided by the trailing-twelve-month net-income growth rate (in percentage points). Adjusts the earnings multiple for the pace of earnings growth.